Work & Activities

Dr. Blanco is the author of more than 160 articles in scientific journals, five patents, 21 chapters in specialized books, and over 240 conference contributions, many as an invited speaker. She has an H-index of 60, and her work has been cited over 10,800 times. She has supervised or is currently supervising 25 PhD theses and has been the principal investigator of 37 research projects. She serves as an expert for the European Commission in the field of nanomedicine and advanced therapies and as a reviewer for various national and international organizations.

Her research focuses on the development of nanomedicines for cancer treatment (particularly pediatric cancer) and on heart and brain tissue regeneration through tissue engineering. Her contributions to drug delivery research have been recognized with numerous national and international awards. Among other distinctions, she is a member of the National Academy of Pharmacy of France and the Academy of Galicia. From 2020 to March 2024, she served as the President of the Spanish Society of Industrial and Galenic Pharmacy (SEFIG).

In 2021, she was inducted into the College of Fellows of the American Institute of Medical and Biological Engineering (AIMBE), one of the most prestigious biomedical engineering associations based in Washington, D.C. In 2022, she was elected a member of the European Academy, and in March 2024, she joined the French Academy of Medicine. Since January 2023, she has been the President of the European Federation for Pharmaceutical Sciences (EUFEPS). From 2018 to 2022, she served as a manager and collaborator in the Biomedicine scientific area of the Spanish State Research Agency (AEI) – Ministry of Science, Innovation, and Universities.